BioSpace News Archive

Biophytis SA announces that patient recruitment at most clinical centers in Brazil and the United States will begin for Part 2 of its COVA Study assessing Sarconeos as a potential treatment for acute respiratory failure associated with COVID-19.

Walt Rosebrough to step down as CEO at the upcoming Annual General Meeting Chief Operating Officer, Dan Carestio, to succeed as President and CEO

Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.708 billion during the fourth quarter of 2020. This represents a decline of (6.8) percent on a reported basis, (8.3) percent on an operational 1 basis and (8.0) percent on an organic 2 basis, all compared to the prior year period.

Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory disorder of central nervous system which was previously known as Devic disease or neuromyelitis optica (NMO).

The global market for cell culture protein surface coatings is slated to expand at a highly promising pace in the next few years, thanks to the vast rise in investments by governments and market players in stem cell research and development activities.

The market is driven by the need for an error-free prescription process and constant government efforts towards quality and the affordable healthcare system.

Filters are connected in numerous phases during the manufacture of small molecular drugs, which is termed as active pharmaceutical ingredients, as well.

Multi-year collaboration will use artificial intelligence (AI) and deep learning to accelerate the invention of new, more sustainable products and technologies for growers

Takeda’s Heritage in Bleeding Disorders and Commitment to Investing in Innovation Support Our Passion for Helping Patients and Our Vision of a Bleed-free World

Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs, announced today that data from non-human primate studies of the companys proprietary fully human Interleukin 12 (IL-12) therapeutic candidate, SON-1010, will be presented at the upcoming American Association for Cancer Research (AACR) Virtual Annual Meeting 2021, April 10-15 and May 17-21.